Background
Brian Rifkin
ICRAKI-ng the code on RRT

This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)

ICRAKI-ng the code on RRT
news
swapnil hiremath
Kidney Week in Denver: Day 3

Day 3 : yet another IgA trial, and we are back with some flozin news: in ADPKD, their effect on hemoglobin, and on BP (with finerenone)

Kidney Week in Denver: Day 3
news
swapnil hiremath
Kidney Week in Denver: Day 2

Day 2 was less exciting: we cover 1 IgA trial (Ravulizumab) along with another calcimimetic, and a pentoxifylline meta-analysis.

Kidney Week in Denver: Day 2
news, Background
Milagros Flores
Kidney Week in Denver: Day 1

Day of Kidney Week 2026. The NephJC crew discusses 6 studies, including some blockbustr IgA news.

Kidney Week in Denver: Day 1
Background
Brian Rifkin
Can Dialysis Outshine Transplant in the Elderly?

This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.

Can Dialysis Outshine Transplant in the Elderly?

TOTW

Tweet of the Week: Urine Eosinophils and NephroCheck

Dr. Faubel nailed the best comment about NephroCheck by reminding us while we pick apart the particulars of NephroCheck that we have some other dragons to slay:

And then Edgar slides in with the appropriate #NephPearl (How does he do that so fast?)

Tweet of the night

We had a great NephJC last night. We had a new contributor who was excellent, Eric Weinhandl of Minnesota.

Dr. Weinhandl works with the new PEER Kidney Care Initiative. It looks like a cool project. Here is some press from Nephrology News and Issues.